Detection of Campylobacter jejuni/C. coli infection in patients with Guillain-Barré Syndrome by serology and culture

New Microbiologica

Volumn 19, Issue 3, 1996, Pages 267-271

  Hariharan, H ^a   Naseema, K ^b   Kumaran, C ^b   Shanmugam, J ^b   Nair, M D ^b   Radhakrishnan, K ^b  

^a UNIVERSITY OF PRINCE EDWARD ISLAND   (Canada)

^b SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY   (India)

Author keywords

Campylobacter; Guillain Barr Syndrome; Serology

Indexed keywords

AUTOANTIBODY; BACTERIUM ANTIBODY; GANGLIOSIDE GM1;

ADOLESCENT; ADULT; ARTICLE; BLOOD; CAMPYLOBACTER JEJUNI; CHILD; ENTEROBACTER INFECTION; ESCHERICHIA COLI; FECES; FEMALE; GRAM NEGATIVE INFECTION; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; POLYRADICULONEUROPATHY;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; AUTOANTIBODIES; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; CHILD; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FECES; FEMALE; G(M1) GANGLIOSIDE; HUMANS; MALE; MIDDLE AGED; POLYRADICULONEUROPATHY;

EID: 0030185421     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. ALLOS, B.M., and BLASER, M.J. (1994). Campylobacter jejuni infection and the Guillain-Barré Syndrome: mechanisms and implications. Zentralblatt fur Bakteriologie. International Journal of Medical Microbiology 281, 544-548.
2. ASPINALL, G.O., FUJIMOTO, S., MCDONALD, A.G., PANG, H., KURJANCZYK, L.A., and PENNER, J.L. (1994). Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barré Syndrome patients mimic human gangliosides in structure. Infection and Immunity 62, 2122-2125.
3. BOLTON, F.J. (1990). Campylobacter, pp. 148-153. In: T.G. Wright and P. Morgan-Capner (ed), ELISA in clinical microbiology laboratory. Public Health Laboratory Service, London, England.
4. GRIFFIN, J.W., and HO, T.W.H. (1993). The Guillain-Barré Syndrome at 75: the Campylobacter connection. Annals of Neurology 34, 125-127.
5. HARIHARAN, H., and PANIGRAHI, D. (1990). Cholera-like enterotoxin in certain Campylobacter jejuni strains: some observations. Microbiologica 13, 7-9.
6. HARIHARAN, H., WRIGHT, T., and LONG, J.R. (1990). Isolation and antimicrobial susceptibility of Campylobacter coli and C. jejuni. Microbiologica 13, 1-6.
7. KUROKI, S., SAIDA, T., NUKINA, M., HARUTA, T., YOSHIKA, M., KOBAYASHI, T., and NAKANISHI, H. (1993). Campylobacter jejuni strains from patients with Guillain-Barré Syndrome belong mostly to Penner serogroup 19 and contains 13-N-Acetylglucosamine residues. Annals of Neurology 33, 243-247.
8. LAMBE, D.W., and FERGUSON, D.A. (1982). Serology of Campylobacter jejuni by tube agglutination and fluorescent antibody methods, pp. 113-116. In D.G. Newell (ed), Campylobacter: epidemiology, pathogenesis and biochemistry. MTP Press Limited, Lancaster England.
9. LAUWERS, S., and PENNER, J.L. (1984). Serotyping Campylobacter jejuni and Campylobacter coli on the basis of thermostable antigens, pp. 51-59. In: J.P. Butzler (ed), Campylobacter infections in man and animals. CRC Press, Boca Raton, Florida.
10. MCDONALD, A.G., PANG, H., KURJANCZYK, L.A., and PENNER, J.L. (1994). Lipopolysaccharides of Campylobacter jejuni serotype 0:19. Structures of core oligosaccharide regions from the serostrain and two bacterial isolates from patients with the Guillain-Barré Syndrome. Biochemistry 33, 241-249.
11. MISHU, B., and BLASER, M.J. (1993). Role of infection due to Campylobacter jejuni in the initiation of Guillain-Barré Syndrome. Clinical Infectious Diseases 17, 104-108.
12. MISHU, B., ILAYAS, A.A., KOSKI, C.L., VRIESENDORP, F., COO, S.D., MITHEN, F.A., and BLASER, M.J. (1993). Serological evidence of previous Campylobacter jejuni infection in patients with the Guillain-Barrè Syndrome. Annals of Internal Medicine 118, 947-953.
13. REES, J.H., GREGSON, N.A., GRIFFITHS, P.L., and HUGHES, R.A.C. (1993). Campylobacter jejuni and Guillain-Barré Syndrome. Quarterly Journal of Medicine 86, 623-634.
14. WALDER, M., and FORSGREN, A. (1982). Enzyme-linked immunosorbent assay (ELISA) for antibodies against Campylobacter jejuni and its clinical application. Acta Pathologica, Microbiologica, et Immunologica Scandinavica. Section B. Microbiology 90, 423-433.
15. WALSH, F.S., CRONIN, M., KOBLAR, S., DOHERTY, P., WINER, J., LEON, A., and HUGHES, R.A.C. (1991). Association between glycoconjugate antibodies and Campylobacter infection in patients with Guillain-Barré Syndrome. Journal of Neuroimmunology 34, 43-51.
16. YUKI, N.B. (1994). Pathogenesis of axonal Guillain-Barrè Syndrome: hypothesis. Muscle and Nerve 17, 680-682.